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e-mail address: heur@usc.edu (M. Heur).Gloria B. Chiu, OD; Dianne Bach, BS; Christos Theophanous, BS; Martin Heur, MD, PhD ⇑AbstractPurpose: To evaluate the use of Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) scleral lens treatment as an
alternative to keratectomy in patients with symptomatic Salzmann’s nodular degeneration (SND).
Methods: A retrospective chart review from July 2009 to May 2013 identified 9 SND patients who were referred for PROSE eval-
uation. Patients who did not complete PROSE fitting or had other corneal comorbidities affecting vision were excluded from the
study, and 7 eyes of 4 patients were included. Three patients were pseudophakic and 1 patient was phakic, and the lens status of
our cohort did not change during the study.
Results: Visual acuity improved from 0.19 ± 0.084 logMAR (approximately 20/31) pre PROSE to 0.028 ± 0.047 logMAR (approxi-
mately 20/21) post PROSE in patients with Salzmann’s nodular degeneration (p = 0.002). OSDI scores improved from 46.9 ± 26.6
pre PROSE to 21.5 ± 18.7 post PROSE in the same cohort (p = 0.02).
Conclusion: The results of this study show that PROSE can provide improvements in visual acuity and function in patients with
Salzmann’s nodular degeneration and offer an alternative to superficial keratectomy.
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Maximilian Salzmann first reported a series of patients
with nodular keratopathy in 1925 that now bears his name.1
Salzmann’s nodular degeneration (SND) is characterized by
subepithelial fibrosis consisting of bluish-white nodules that
usually affects the mid-peripheral to peripheral cornea. The
etiology of SND is unclear; it is thought to be a degenerative
process triggered by chronic ocular surface inflammation.
Histological analyses show that the nodules are composed
of hyaline degeneration of collagen, cellular debris, and elec-
tron-dense hyaline deposits.2 Peripheral location of the nod-
ules can lead to flattening of the central cornea resulting in a
hyperopic shift resulting in vision loss.3 Patients can also
experience recurrent erosions, photophobia, and epiphorasecondary to ocular surface irritation from the nodules.4
Many SND patients respond well to conventional treatments
such as artificial tears, topical steroids, and bandage contact
lenses. There is a group of patients who are refractory to con-
ventional therapy and require surgical intervention for relief.
Various surgical techniques have been described for the
removal of Salzmann’s nodules, including manual superficial
keratectomy and phototherapeutic keratectomy.4,5 Surgical
intervention is unfortunately not a viable option for some
patients who fail conventional therapy, and their options
become severely limited.
Prosthetic Replacement of the Ocular Surface Ecosystem
(PROSE) scleral lens (Boston Foundation for Sight, Needham,
Massachusetts, USA), utilizes a custom fitted scleral contact
lens that vaults the entire cornea and limbus, bathing theme:
al.com
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lens fitting process involves the use of a proprietary software
program that allows for a highly customizable device that
precisely fits the curvature of each patient’s eye to maximize
vision and comfort.6 We hypothesized that PROSE scleral
lenses could be used as an alternative to superficial keratec-
tomy in patients with SND who failed conventional treat-
ment. Previous reports have shown that PROSE scleral
lenses significantly improve visual acuity and functioning for
patients with various ocular surface diseases.7–13 Prior to
our study, the use of PROSE scleral lens as an alternative to
superficial keratectomy in SND patients was not evaluated.
The purpose of this study was to evaluate the results of our
experience with using PROSE scleral lenses for the manage-
ment of SND patients who had failed conventional treat-
ments with outcomes based on visual acuity and function.
To our knowledge this study represents the first report of
using PROSE scleral lenses as an alternative to superficial ker-
atectomy in patients with Salzmann’s nodular degeneration.Methods
Subjects
The University of Southern California Institutional Review
Board reviewed and approved this study. A retrospective
chart review identified 9 Salzmann’s nodular degeneration
(SND) patients who failed conventional therapy and were
subsequently referred for PROSE scleral lens fitting between
July 2009 and May 2013. Patients who did not complete the
fitting and a patient with keratoconus and SND were
excluded from the study. A total of 7 eyes of 4 patients
who completed PROSE scleral lens fitting were included in
this study.Visual acuity
Visual acuities (Va) were obtained before and after PROSE
fitting using a Snellen chart under standardized illumination
with the projected image calibrated for the length of the
examination room. Pre-PROSE Va was obtained using either
manifest refraction or the patient’s device at the time of initial
evaluation. Post-PROSE Va was obtained at completion of
the lens fitting. Visual acuities were then converted from
Snellen acuity to logarithm of the minimal angle of resolution
(logMAR) acuity for statistical analysis.14Figure 1. Slitlamp photo of patient with Salzmann’s nodular degenera-
tion. The subepithelial nodules are present in the superior peripheral
cornea. The PROSE scleral lens vaults the entire cornea and limbus,
including the peripheral areas of subepithelial fibrosis (⁄), and rests on the
adjacent conjunctiva (arrows).Visual function
Visual function, pre and post PROSE fitting, were assessed
using the Ocular Surface Disease Index (OSDI), a validated
12-item questionnaire designed to grade severity of ocular
discomfort and vision-related function.15 Each item is scored
on a scale of 0–4, and the final score is calculated by summing
the individual scores of all questions answered  100 divided
by the total number of questions answered  4. Pre-PROSE
OSDI scores were obtained from the patient at the initial con-
sultation visit, and post-PROSE OSDI scores were obtained
several months after the last fitting visit via telephone by a
trained interviewer (C.T.) not involved in patient care.Statistical analysis
Statistical analyses using paired, two-tailed t-tests were
performed to compare pre and post PROSE visual acuity
and OSDI scores.
Results
A total of 5 eyes from 3 individuals with Salzmann’s nodu-
lar degeneration who completed PROSE fitting were
included in this retrospective review study. There was 1 male
and 3 female patients in our group with a mean age of
64.3 ± 8.4 years at the time of PROSE fitting. Three patients
were pseudophakic and 1 patient was phakic, and the lens
status of our cohort did not change during the study. The
PROSE scleral lens was fitted to vault the entire cornea and
limbus, including the peripheral areas of subepithelial fibrosis
(Fig. 1).
The mean pre-PROSE visual acuity (Va) of our SND cohort
was 0.19 ± 0.084 logMAR, and the mean post-PROSE Va was
0.028 ± 0.047 logMAR, which represented a significant
improvement over the pre-PROSE acuities (p = 0.002)
(Fig. 2). In terms of Snellen acuities, our SND patients
improved from approximately 2 lines from 20/31 to 20/21
after being fitted with PROSE scleral lenses.
We waited a minimum of 6 months before conducting the
post-PROSE OSDI surveys by telephone. All patients com-
pleted the post-PROSE OSDI survey, and they reported
wearing the lens at all times during waking hours. The mean
pre-PROSE OSDI score of our SND cohort was 46.9 ± 26.6
(Fig. 3). The mean post-PROSE OSDI score of our SND cohort
was 21.5 ± 18.7, representing a significant improvement
(p = 0.02).
Discussion
This retrospective chart review study demonstrated that
PROSE scleral lenses significantly improve visual acuity and
function in patients with Salzmann’s nodular degeneration
(SND). The mean visual acuity (Va) of the group improved sig-
nificantly (p = 0.002) following PROSE scleral lens fitting. The
mean best-corrected pre-PROSE Va of 0.19 ± 0.084 logMAR,
approximately 20/31, indicates that SND patients have
Figure 2. Visual acuities pre and post PROSE fitting represented as
logarithm of the minimal angle of resolution (logMAR). The mean visual
acuity (Va) of the cohort improved from 0.19 ± 0.084 logMAR pre-PROSE
to 0.028 ± 0.047 logMAR post-PROSE (⁄p = 0.002).
Figure 3. Ocular Surface Disease Index (OSDI) scores pre and post
PROSE fitting. The mean OSDI score of the entire cohort improved from
46.9 ± 26.6 pre-PROSE to 21.5 ± 18.7 post-PROSE (⁄p = 0.02).
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tral cornea is relatively uninvolved. The improvement in mean
Va, post PROSE fitting, was 0.028 ± 0.047 logMAR or
approximately 20/21, and likely resulted from correction of
the irregular astigmatism induced from the subepithelial
fibrosis.
The mean pre-PROSE OSDI score for the entire group was
46.9 ± 26.6, indicating significant impairment in their daily
activities due to their compromised vision. The improvement
in the OSDI scores following PROSE fitting, 21.5 ± 18.7,
p = 0.02, indicates that our cohort of patients experienced
a significant improvement in visual function without resorting
to surgery. The OSDI results are consistent with our past
experience with keratoconus and Stevens–Johnson syn-
drome patients who were fitted with PROSE scleral lenses.8,16
Although almost all patients with SND respond well to photo-
therapeutic superficial keratectomy, the patients included in
this study opted to explore nonsurgical options citing patient
preference after not getting sufficient relief from conven-
tional therapy.One of the strengths of this study was incorporating visual
function in the outcome analysis. The use of OSDI survey pro-
vides a valid and reliable method to quantitatively measure
improvements in visual function following PROSE scleral lens
fitting in the context of symptoms, vision-related function,
and environmental triggers. Although the small sample size
precluded subcategory analysis, there was a general trend
for improvements in symptoms, vision-related function, and
environmental triggers following PROSE fitting. Our findings
demonstrate the importance and value of using visual func-
tion and quality, in addition to visual acuity, as a measure
of the efficacy and benefits of PROSE scleral lens therapy.
The post-PROSE OSDI surveys were conducted with the
interviewer blinded to patient symptoms, and provided an
objective assessment of visual functioning before and after
the lens was fitted.
Aside from being a retrospective analysis, another limita-
tion of this study is the small size of our cohort. This is likely
due to the fact that most patients with symptomatic SND do
well with either conventional therapy or phototherapeutic/
superficial keratectomy. High success rate and low lens wear
failure rate among those included in the study reflects an
ascertainment bias because the study included only patients
who were fitted with the PROSE lens and excluded patients
who had PROSE lens consultation, but who were not fitted
with the lens. Some of the reasons for not completing the fit-
ting process included lack of insurance coverage, patients
changing their mind regarding surgery and being lost to fol-
low up. As our experience grows, it will be interesting to
compare pre and post OSDI scores between patients who
opt for PROSE versus keratectomy. As an added benefit,
PROSE therapy avoids potential complications such as hyper-
opic shift, persistent epithelial defects, and induction of
higher order aberrations following keratectomy. The results
of this study show that the PROSE scleral lens can offer an
alternative to phototherapeutic or superficial keratectomy
for patients for whom surgery is not a viable option.
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